Benchmark elevated its price objective for Texas Instruments (NASDAQ:TXN) to $250.00 from $220.00 on Wednesday while retaining a Buy recommendation on the semiconductor maker. The new target implies meaningful upside from the stock's prevailing price of $196.63 for the company, which holds a market capitalization of $178.66 billion.
The move by Benchmark followed Texas Instruments' December-quarter performance, which was in line with expectations, and a March-quarter outlook that came in above analyst forecasts. The company reported $17.68 billion in revenue on a trailing twelve‑month basis.
Shares of Texas Instruments jumped in after‑hours trading on Wednesday, trading as much as 8% higher after the earnings disclosure. At the current price level the stock is trading at a price-to-earnings ratio of 35.95, a level InvestingPro data flags as relatively high versus the company's historical range.
Management broke a recent pattern of more cautious guidance by delivering an upbeat outlook for the March quarter - the first time in over 20 years the company has guided for sequential first-quarter growth. Benchmark highlighted that Texas Instruments has recorded sequential first-quarter growth in only five of the last 20 years, with the most recent occurrences listed as the first quarters of 2025 and 2022.
On a quarterly results basis, Texas Instruments reported fourth-quarter 2025 earnings that slightly missed consensus on both per-share earnings and revenue. The company posted an EPS of $1.27, compared with the expected $1.29, and recorded revenue of $4.42 billion versus the anticipated $4.45 billion.
Analyst responses to the quarter and guidance have varied. Baird raised its price target to $225 while maintaining an Outperform rating and cited a positive first-quarter outlook. UBS lifted its target to $260 and kept a Buy rating, pointing to improving revenue trends and constructive commentary on backlog. Mizuho increased its target to $160 but retained an Underperform rating, noting that December-quarter revenue aligned with consensus at $4.4 billion and that the company guided March-quarter revenue slightly above expectations at $4.5 billion.
These adjustments underscore differing analyst views on Texas Instruments' near-term trajectory despite the stronger-than-expected March guidance and the small miss on fourth-quarter results. The share price response in after-hours trading reflected investor emphasis on the forward-looking guidance.
Below is a concise recap of the principal data points cited by analysts and company disclosures:
- Benchmark raised target to $250 from $220 and kept Buy.
- Current share price referenced at $196.63; market cap at $178.66 billion.
- Trailing 12-month revenue: $17.68 billion.
- After-hours share move: up as much as 8% following earnings release.
- Trailing P/E ratio: 35.95, indicated as relatively high by InvestingPro data.
- Fourth-quarter 2025 results: EPS $1.27 vs expected $1.29; revenue $4.42 billion vs expected $4.45 billion.
- Analyst target moves: Baird to $225 (Outperform); UBS to $260 (Buy); Mizuho to $160 (Underperform).
- Company guided for sequential first-quarter growth - a pattern seen in five of the last 20 years, most recently in the first quarters of 2025 and 2022.
In aggregate, the data and analyst reactions present a mixed picture: a modest miss on the latest reported quarter but stronger guidance that drove both analyst target revisions and a sharp after‑hours market response.